Afirma^® Thyroid FNA Analysis combines expert cytopathology with the clinically and analytically validated Afirma Gene Expression Classifier to deliver accurate and actionable results on FNA. More on Afirma.

Veracyte is pioneering the emerging field of molecular cytology by focusing on disease states that have high rates of ambiguous diagnostic test results. More on our pipeline.

Press Release: Genzyme and Veracyte Announce Global Co-Promotion Agreement to Deliver Personalized Solution for Thyroid Patients (Jan 20, 2012)

Press Release: Medicare Coverage for Afirma Gene Expression Classifier 
(Jan 9, 2012)